i.almeida
TL2 Moderator · Pune
Contributes reviews on supplier material. Based in Pune.
Joined 8 April 2025 · last posted 5d
77 posts, newest first. Showing up to 150.
-
A 10 mg vial reconstituted three different ways, compared Replied, post #34 · Practice › Reconstitution · 23 Jul 2026 · 7 likes This follows post #31 rather than contradicting it. Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #116 · Compounds › Semaglutide · 22 Jul 2026 · 11 likes Coming back to post #114, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Pooling trials with different estimands Replied, post #114 · Evidence › Meta-analyses · 20 Jul 2026 · 0 likes Coming back to post #112, because the follow-up matters more than the original answer. Why forest plots are more informative than pooled numbers: they show the…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #84 · Analytics › Impurities & related substances · 16 Jul 2026 · 1 like Deamidation at asparagine and glutamine: adds 1 approximately. Frequently appears as a close-eluting pair. It is a chemical modification that occurs during storage.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #43 · Pharmacology › Receptor biology · 13 Jul 2026 · 9 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #70 · Access › Insurance & coverage · 12 Jul 2026 · 20 likes Denial letters: the stated reason tells you exactly what to submit next. A denial is not final; it is a specification for an appeal. Reading the reason carefully and…
-
Substitution between formats during a shortage — what changed since Replied, post #10 · Access › Shortages · 12 Jul 2026 · 29 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #50 · Evidence › Journal club · 11 Jul 2026 · 3 likes Coming back to post #48, because the follow-up matters more than the original answer. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #50 · Nutrition & Training › Protein & intake · 10 Jul 2026 · 0 likes Micronutrition alongside protein: eating protein foods that are also good sources of micronutrients (iron, B vitamins, zinc) solves two problems at once.
-
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #14 · Practice › Side effects · 4 Jul 2026 · 31 likes Coming back to post #12, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Does a peptide degrade silently, with no visual change? Replied, post #53 · Practice › Storage & stability · 21 Jun 2026 · 12 likes This follows post #50 rather than contradicting it. Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure…
-
Does dual agonism explain the effect size, or is it dose? Replied, post #47 · Compounds › Tirzepatide · 20 Jun 2026 · 12 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Official shortage notices and what they authorise Replied, post #69 · Access › Shortages · 26 May 2026 · 0 likes Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
-
Introducing myself: pharmacist, sceptic, reluctant participant Replied, post #17 · Lounge › Introductions · 11 May 2026 · 1 like What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #38 · Practice › Reconstitution · 5 May 2026 · 3 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #102 · Compounds › Tirzepatide · 29 Apr 2026 · 18 likes Worth separating two things that post #98 runs together. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is minimal at that dose. It is…
-
Coming back to: Why our vendor pages link the storefront and mark it sponsored Started this topic · Sourcing › Vendor reports · 8 Apr 2026 · 59 likes Why our vendor pages link the storefront and mark it sponsored I have a specific reason for asking rather than idle curiosity, and the context is below. Structured…
-
Follow-up: State-level differences that actually matter Replied, post #71 · Regional › North America · 7 Apr 2026 · 2 likes post #70 answers the question as asked. The question underneath it is different. Telehealth prescribing: widespread in the US and varying in quality. Models without a…
-
A widely repeated interaction claim that turns out to be unsupported — what changed since Replied, post #20 · Practice › Interactions · 3 Apr 2026 · 5 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
-
Constipation management, with a dietitian's contribution Replied, post #47 · Practice › Side effects · 1 Apr 2026 · 18 likes Picking up post #44: that is the part I would want checked first. Delayed gastric emptying: the mechanism behind much of the gastrointestinal side-effect profile. At…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #62 · Compounds › Tirzepatide · 29 Mar 2026 · 31 likes post #61 answers the question as asked. The question underneath it is different. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #89 · Clinical › Special populations · 28 Mar 2026 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
What a documentation review can and cannot tell you — a second dataset Replied, post #2 · Sourcing › Independent verification · 22 Mar 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
An ABAB design with a data table and honest limitations — a second dataset Replied, post #86 · Research Methods › N-of-1 designs · 21 Mar 2026 · 1 like I read post #84 twice before replying, because I had assumed the opposite. Designing a personal experiment that could actually change your mind: that is the standard…
-
Journal club: STEP 8 and the fairness of the comparator dose — a second dataset Replied, post #2 · Evidence › Journal club · 18 Mar 2026 · 16 likes Worth separating two things that the opening post runs together. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #42 · Access › International · 17 Mar 2026 · 0 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #97 · Clinical › Bloodwork · 10 Mar 2026 · 1 like Lipid panel interpretation: total, LDL, HDL, triglycerides all on one panel. Reading them together is more informative than reading one value in isolation. An elevated…
-
Request: export my own posts — one year on Replied, post #57 · Meta › Feature requests · 10 Mar 2026 · 13 likes post #56 is right about the mechanism and I think understates the practical bit. Duplicate requests: if several people request the same feature, the requests often get…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #11 · Sourcing › Logistics · 5 Mar 2026 · 12 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #33 · Analytics › Impurities & related substances · 24 Feb 2026 · 30 likes Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Ultrasound and skinfolds: operator dependence in practice — what changed since Replied, post #17 · Outcomes › Body composition · 18 Feb 2026 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #55 · Practice › Dosing & titration · 18 Feb 2026 · 11 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Mass error in ppm: the arithmetic and the caveat Replied, post #51 · Analytics › Mass spectrometry · 13 Feb 2026 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #59 · Clinical › Special populations · 24 Jan 2026 · 23 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
-
Second pass at: What to keep a record of at the point of payment Replied, post #4 · Sourcing › Payments · 21 Jan 2026 · 3 likes post #2 is right about the mechanism and I think understates the practical bit. Chargeback reality: if you pay by credit card and the supplier does not deliver, you can…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #100 · Analytics › Home & field testing · 8 Jan 2026 · 32 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #122 · Practice › Reconstitution · 18 Dec 2025 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #94 · Practice › Reconstitution · 12 Dec 2025 · 0 likes I read post #92 twice before replying, because I had assumed the opposite. A vial that will not fully dissolve: check in order: is the diluent genuinely room…
-
MHRA statements, read directly Replied, post #42 · Regional › UK & Ireland · 3 Dec 2025 · 11 likes NHS access has been restricted by commissioning criteria, not by licensing. Specialist weight-management services in many areas require prior weight-loss attempts, BMI…
-
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #22 · Compounds › Tirzepatide · 3 Dec 2025 · 13 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Prescription requirements and telehealth models Replied, post #27 · Sourcing › Regulatory · 23 Nov 2025 · 30 likes I read post #25 twice before replying, because I had assumed the opposite. Regulatory positions change: a compound's status today might differ from its status a year…
-
[2026 update] How much of the diluent volume the powder itself displaces Replied, post #6 · Practice › Reconstitution · 22 Nov 2025 · 0 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #123 · Start Here › How to Ask · 21 Nov 2025 · 1 like Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Personal import allowances, compared — a second dataset Replied, post #23 · Access › International · 17 Nov 2025 · 12 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #88 · Documentation › Doc review · 6 Nov 2025 · 6 likes On post #84 — agreed on the reasoning, with one qualification. New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new…
-
Revisiting: Why tirzepatide titration schedules have more steps than semaglutide's Replied, post #3 · Compounds › Tirzepatide · 5 Nov 2025 · 13 likes Dual agonism versus dose: how much of tirzepatide's effect is the GIP component and how much is simply achieving higher receptor engagement? The honest answer is that…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #95 · Practice › Storage & stability · 21 Oct 2025 · 12 likes post #94 answers the question as asked. The question underneath it is different. Temperature excursions: if a vial sat at room temperature for a time, the question is…
-
Semaglutide versus liraglutide head to head: reading STEP 8 carefully Replied, post #73 · Compounds › Semaglutide · 11 Oct 2025 · 23 likes On post #69 — agreed on the reasoning, with one qualification. The mass figure differs between sources because of how the different entities report it. The monoisotopic…
-
Why the timeline is on the right and not the left Replied, post #74 · Meta › Site feedback · 27 Sep 2025 · 6 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #4 · Evidence › Preprints · 25 Sep 2025 · 0 likes Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled knowledge. Use it for hypothesis generation and for…
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #77 · Practice › Side effects · 20 Sep 2025 · 0 likes Picking up post #74: that is the part I would want checked first. Timeline matters: onset, duration, pattern over days or weeks, relationship to injection and to meals…
-
Column chemistry choices for a 40-residue peptide Replied, post #40 · Analytics › HPLC & UHPLC · 19 Sep 2025 · 0 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
An inter-laboratory comparison on one lot, tabulated — what changed since Started this topic · Analytics › Method validation · 17 Sep 2025 · 12 likes An inter-laboratory comparison on one lot, tabulated — what changed since — setting out what I have, and where I think it stops being reliable. I would like to…
-
Discussing something you have already been doing Replied, post #4 · Clinical › Prescriber conversations · 12 Sep 2025 · 1 like Worth separating two things that post #3 runs together. Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #29 · Compounds › Tirzepatide · 20 Aug 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #6 · Analytics › Method validation · 7 Aug 2025 · 7 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Canadian access and provincial variation — one year on Replied, post #19 · Regional › North America · 23 Jul 2025 · 1 like Telehealth prescribing: widespread in the US and varying in quality. Models without a clinician reviewing measurements and history are not recommended by this community.
-
Sodium, potassium and magnesium when intake drops Replied, post #66 · Nutrition & Training › Hydration & electrolytes · 19 Jul 2025 · 7 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #73 · Outcomes › Progress reports · 30 Jun 2025 · 0 likes I read post #71 twice before replying, because I had assumed the opposite. Longitudinal report with the method stated: same scale, same time of day, same conditions. A…
-
Counter-ion content and its effect on measured mass Replied, post #62 · Analytics › Mass spectrometry · 11 Jun 2025 · 8 likes On post #58 — agreed on the reasoning, with one qualification. Resolution: "high resolution" commonly means
-
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #10 · Sourcing › Vendor reports · 8 Jun 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #6 · Devices › Pens & autoinjectors · 7 Jun 2025 · 1 like I read post #4 twice before replying, because I had assumed the opposite. Storage after first use: most pens can be stored at room temperature after first use, even if…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #93 · Sourcing › Red flags · 10 May 2025 · 0 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
-
When "no data" is the complete and final answer Replied, post #163 · Compounds › Other compounds · 29 Apr 2025 · 25 likes Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates appetite. The documented adverse profile includes blood pressure elevation…
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #14 · Evidence › Trials · 19 Apr 2025 · 16 likes Surrogate endpoints: an endpoint that is not the outcome that matters but is measured as a stand-in. HbA1c is a surrogate for long-term glucose control and the…
-
Journal club: SURMOUNT-1, read without the press release Replied, post #95 · Evidence › Journal club · 12 Apr 2025 · 9 likes post #94 answers the question as asked. The question underneath it is different. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic…
-
Retatrutide dose escalation in the published trials Replied, post #75 · Compounds › Retatrutide · 1 Apr 2025 · 1 like Worth separating two things that post #71 runs together. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect…
-
Coverage for the indication versus for the drug Replied, post #11 · Access › Insurance & coverage · 27 Mar 2025 · 0 likes This follows post #8 rather than contradicting it. Coverage for weight management versus diabetes: many formularies cover these compounds for type 2 diabetes but not…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #61 · Practice › Reconstitution · 23 Mar 2025 · 3 likes post #60 answers the question as asked. The question underneath it is different. Choosing a concentration on purpose rather than by accident: starting with "I want to…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #92 · Sourcing › Vendor reports · 17 Mar 2025 · 18 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #71 · Sourcing › Vendor reports · 17 Mar 2025 · 1 like Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the other mass is water, counter-ion, and excipient. Purity and content are…
-
Validating a method you did not develop — does this still hold? Replied, post #111 · Analytics › Method validation · 13 Mar 2025 · 5 likes Coming back to post #109, because the follow-up matters more than the original answer. Robustness: the method gives consistent results when minor parameters vary.…
-
Scheduled maintenance and what will be unavailable Replied, post #52 · Meta › Announcements · 23 Feb 2025 · 0 likes On post #48 — agreed on the reasoning, with one qualification. Feedback to announcements: if you have feedback on an announced change (not a question, but your…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #16 · Analytics › COA interpretation · 17 Jan 2025 · 24 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Relative retention time as a better inter-laboratory comparator — does this still hold? Replied, post #8 · Analytics › Method validation · 29 Aug 2024 · 4 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Orforglipron as a non-peptide: what changes when the molecule is small Replied, post #13 · Compounds › Oral incretins · 28 Aug 2024 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg…
-
Where the four-week escalation interval comes from, and what it is not Replied, post #41 · Practice › Dosing & titration · 7 Jul 2024 · 14 likes This follows post #38 rather than contradicting it. For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add…